The cost-effectiveness of spinal cord stimulation for complex regional pain syndrome

Value in Health

Volumn 13, Issue 6, 2010, Pages 735-742

  Kemler, Marius A ^a   Raphael, Jon H ^b   Bentley, Anthony ^c   Taylor, Rod S ^d  

^a MARTINI HOSPITAL   (Netherlands)

^b BIRMINGHAM CITY UNIVERSITY   (United Kingdom)

^c Decision Resources Group   (United Kingdom)

^d PENINSULA MEDICAL SCHOOL   (United Kingdom)

Author keywords

complex regional pain syndrome; cost utility analysis; cost effectiveness; decision analytic modeling

Indexed keywords

ADULT; AGED; ARTICLE; COMPLEX REGIONAL PAIN SYNDROME; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; ELECTRIC BATTERY; FEMALE; HEALTH CARE COST; HUMAN; MALE; MONEY; PRIORITY JOURNAL; PROBABILITY; PULSE GENERATOR; QUALITY ADJUSTED LIFE YEAR; SPINAL CORD STIMULATION;

EID: 77956377869     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1111/j.1524-4733.2010.00744.x     Document Type: Article

References (26)

1. Bruehl S, Harden RN, Galer BS, et al. Complex regional pain syndrome: are there distinct subtypes and sequential stages of the syndrome? Pain 2002 95 : 119 124.
2. Sandroni P, Benrud-Larson LM, McClelland RL, et al. Complex regional pain syndrome type I: incidence and prevalence in Olmsted County, a population-based study. Pain 2003 103 : 199 207.
3. Forouzanfar T, Kemler MA, Weber WE, et al. Spinal cord stimulation in complex regional pain syndrome: cervical and lumbar devices are comparably effective. Br J Anaesth 2004 92 : 348 353.
4. Perez RS, Kwakkel G, Zuurmond WW, et al. Treatment of reflex sympathetic dystrophy (CRPS type 1): a research synthesis of 21 randomized clinical trials. J Pain Symptom Manage 2001 21 : 511 526.
5. Stanton-Hicks M. Complex regional pain syndrome: manifestations and the role of neurostimulation in its management. J Pain Symptom Manage 2006 31 (Suppl S20 4.
6. Kemler MA, Barendse GA, van Kleef M, et al. Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. N Engl J Med 2000 343 : 618 624.
7. Kemler MA, De Vet HC, Barendse GA, et al. The effect of spinal cord stimulation in patients with chronic reflex sympathetic dystrophy: two years' follow-up of the randomized controlled trial. Ann Neurol 2004 55 : 13 18.
8. Kemler MH, de Vet HC, Barendse GA, et al. Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial. J Neurosurg 2008 108 : 292 298.
9. Taylor RS, Drummond MF, Salkeld G, Sullivan SD. Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle. BMJ 2004 23 : 972 975.
10. Detsky AS, Laupacis A. Relevance of cost-effectiveness analysis to clinicians and policy makers. JAMA 2007 298 : 221 224.
11. NICE. Spinal Cord Stimulation for Chronic Pain of Neuropathic Or Ischaemic Origin. London : National Institute for Health and Clinical Excellence, 2008. Available from: http://www.nice.org.uk/Guidance/TA159 [Accessed September 30, 2009].
12. Merskey H, Bogduk N. Classification of chronic pain. In : Merskey H, Bogduk N, eds. Descriptions of Chronic Pain Syndromes and Definition of Pain Terms (2nd ed.). Seattle, WA : IASP Press, 1994.
13. Taylor RJ, Taylor RS. Spinal cord stimulation for failed back surgery syndrome: a decision-analytic model and cost-effectiveness analysis. Int J Technol Assess Health Care 2005 21 : 351 358.
14. Kumar K, Hunter G, Demeria D. Spinal cord stimulation in treatment of chronic benign pain: challenges in treatment planning and present status, a 22-year experience. Neurosurgery 2006 58 : 481 486.
15. Dolan P. Modelling valuations for EuroQoL health states. Med Care 1997 35 : 1095 1108.
16. Kumar K, Taylor RS, Jacques L, et al. Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain 2007 132 : 179 188.
17. Manca A, Kumar K, Taylor RS, et al. Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS Trial). Eur J Pain 2008 12 : 1047 1058.
18. NICE. Guide to the Methods of Technology Appraisal. London : National Institute for Health and Clinical Excellence, 2008. Available from: http://www.nice.org.uk/media/B52/A7/TAMethodsGuideUpdatedJune2008.pdf [Accessed September 30, 2009].
19. Fenwick E, Claxton K, Sculpher M. Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Econ 2001 10 : 779 787.
20. Rawlins MD, Culyer AJ. National Institute for Clinical Excellence and its value judgments. BMJ 2004 329 : 224 227.
21. Kemler MA, Furnée CA. Economic evaluation of spinal cord stimulation for chronic reflex sympathetic dystrophy. Neurology 2002 59 : 1203 1209.
22. Simpson EL, Duenas A, Holmes MW, et al. Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin: systematic review and economic evaluation. Health Technol Assess 2009 13 (iii ix x, 1 154.
23. Hornberger J, Kumar K, Verhulst E, et al. Rechargeable spinal cord stimulation versus non-rechargeable systems for patients with failed back surgery syndrome: a cost-consequences analysis. Clin J Pain 2008 24 : 244 252.
24. Taylor RS. Epidemiology of refractory neuropathic pain. Pain Pract 2006 6 : 22 6.
25. National Health Service England, Hospital Episodes Statistics. Totals report for Procedure A483 (Insertion of neurostimulator adjacent to spinal cord) for the all SHA's (Strategic Health Authorities) of treatment. 2005/06. Available from: http://www.hesonline.nhs.uk/Ease/servlet/ContentServer?siteID= 1937 [Accessed May 7, 2010].
26. UK Office of National Statistics. Available from: http://www.statistics. gov.uk [Accessed September 30, 2009].